Forma Therapeutics Holdings (FMTX) Tops Q1 EPS by 12c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Forma Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
May 6, 2022 7:05 AM EDTClinical programs advancing in rare hematologic diseases and cancers
May 26 R&D Day to focus on research pipeline strategy and expanded development programs
Cash balance of $441.3 million positions company with runway through the third quarter of 2024
WATERTOWN, Mass.--(BUSINESS WIRE)-- Forma Therapeutics Holdings, Inc. (Nasdaq:... More



